Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kimitoshi Nakamura, Murray Robertson, Gang Liu, Peter Dickie, Kyoko Nakamura, Ji Qing Guo, Henry J. Duff, Michal Opas, Katherine Kavanagh, Marek Michalak
Published in Volume 107, Issue 10
J Clin Invest. 2001; 107(10):1245–1253 doi:10.1172/JCI12412
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Generation of cardiac-specific calreticulin overexpresser transgenic mice. (a) Calreticulin cDNA encoding full-length protein including the NH2-terminal signal sequence and the COOH-terminal KDEL ER retrieval signal was subcloned downstream from α-cardiac MHC promoter. The arrows indicate the PCR primers used for recognition of the transgene. (bd) Western blot analysis of proteins extracted from control and transgenic mice. The blot was probed with the anti-HA antibodies (b and c) or with the rabbit anti-calreticulin antibodies (d). (e) Kaplan-Meier survival analysis of calreticulin transgenic mouse lines. hGH, human growth factor polyA sequences.